The DOI matches its Crossref record; 365 of the 365 references it cites were found in a registry or an index.
Antioxidants as treatment for neurodegenerative disorders
Abstract
Oxidative stress is a ubiquitously observed hallmark of neurodegenerative disorders. Neuronal cell dysfunction and cell death due to oxidative stress may causally contribute to the pathogenesis of progressive neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, as well as acute syndromes of neurodegeneration, such as ischaemic and haemorrhagic stroke. Neuroprotective antioxidants are considered a promising approach to slowing the progression and limiting the extent of neuronal cell loss in these disorders. The clinical evidence demonstrating that antioxidant compounds can act as protective drugs in neurodegenerative disease, however, is still relatively scarce. In the following review, the available data from clinical, animal and cell biological studies regarding the role of antioxidant neuroprotection in progressive neurodegenerative disease will be summarised, focussing particularly on Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. The general complications in developing potent neuroprotective antioxidant drugs directed against these long-term degenerative conditions will also be discussed. The major challenges for drug development are the slow kinetics of disease progression, the unsolved mechanistic questions concerning the final causalities of cell death, the necessity to attain an effective permeation of the blood-brain barrier and the need to reduce the high concentrations currently required to evoke protective effects in cellular and animal model systems. Finally, an outlook as to which direction antioxidant drug development and clinical practice may be leading to in the near future will be provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–365 of 365
Bender, E., & Kadenbach, B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01773-1 · Cited by 197
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
Tabrizi, S. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2683 · Cited by 197
Inflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Tarnopolsky, M. A., & Beal, M. F. (2001) · Annals of Neurology · doi:10.1002/ana.1028 · Cited by 195
Progression after chronic manganese exposure
Huang, C.-C., Lu, C.-S., Chu, N.-S., Hochberg, F., Lilienfeld, D., Olanow, W., & Calne, D. B. (1993) · Neurology · doi:10.1212/wnl.43.8.1479 · Cited by 194
Apoptosis and Alzheimer's disease
Behl, C. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070021 · Cited by 193
Self-citationDABBENI-SALA, F., DI Santo, S., FRANCESCHINI, D., D. SKAPER, S., & PIETRO GIUSTI, A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0129com · Cited by 192
Randomized, Double-Blind, Controlled Trial of Acetylcysteine in Amyotrophic Lateral Sclerosis
Louwerse, E. S., Weverling, G. J., Bossuyt, P. M. M., Meyjes, F. E. P., & de Jong, J. M. B. V. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300031009 · Cited by 188
Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
Callier, S., Morissette, M., Grandbois, M., Pélaprat, D., & Di Paolo, T. (2001) · Synapse · doi:10.1002/syn.1067 · Cited by 186
van Dongen, M. C. J. M., van Rossum, E., Kessels, A. G. H., Sielhorst, H. J. G., & Knipschild, P. G. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02589.x · Cited by 186
Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
Chase, T. N. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s17 · Cited by 180
Jung, C., Rong, Y., Doctrow, S., Baudry, M., Malfroy, B., & Xu, Z. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01784-0 · Cited by 177
Nelson, L. M., McGuire, V., Longstreth, W. T., & Matkin, C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010183 · Cited by 174
IMAM, S. Z., EL‐YAZAL, J., NEWPORT, G. D., ITZHAK, Y., CADET, J. L., SLIKKER, W., & ALI, S. F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03646.x · Cited by 173
Oxidative Stress and Parkinson's Diseasea
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 173
Pasinetti, G. M. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981001)54:1<1::aid-jnr1>3.0.co;2-m · Cited by 170
Parkinson Study Group (1996) · Annals of Neurology · doi:10.1002/ana.410390106 · Cited by 170
Boveris, A., & Cadenas, E. (2000) · IUBMB Life · doi:10.1080/15216540051080912 · Cited by 168
Creatine monohydrate increases strength in patients with neuromuscular disease
Tarnopolsky, M., & Martin, J. (1999) · Neurology · doi:10.1212/wnl.52.4.854 · Cited by 165
Excitotoxins in Neuronal Apoptosis and Necrosis
Nicotera, P., & Lipton, S. A. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00001 · Cited by 165
Pöeggeler, B., Miravalle, L., Zagorski, M. G., Wısnıewskı, T., Chyan, Y., Zhang, Y., Shao, H., Bryant‐Thomas, T., Vidal, R., Frangione, B., et al. (2001) · Biochemistry · doi:10.1021/bi0114269 · Cited by 165
Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
Shoulson, & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430309 · Cited by 165
Gutzmann, H., & Hadler, D. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_30 · Cited by 162
The Importance of Using Scientific Principles in the Development of Medicinal Agents from Plants
Talalay, P., & Talalay, P. (2001) · Academic Medicine · doi:10.1097/00001888-200103000-00010 · Cited by 162
Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease
Ebadi, M., Govitrapong, P., Sharma, S., Muralikrishnan, D., Shavali, S., Pellett, L. J., Schafer, R., Albano, C. B., & Eken, J. (2001) · Neurosignals · doi:10.1159/000046889 · Cited by 162
Intramembrane proteolysis by presenilins
Steiner, H., & Haass, C. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043065 · Cited by 161
Risk factors for parkinson’s disease: The leisure world cohort study
Paganini-Hill, A. (2001) · Neuroepidemiology · doi:10.1159/000054770 · Cited by 159
Thal, L. J., Carta, A., Clarke, W. R., Ferris, S. H., Friedland, R. P., Petersen, R. C., Pettegrew, J. W., Pfeiffer, E., Raskind, M. A., Sano, M., et al. (1996) · Neurology · doi:10.1212/wnl.47.3.705 · Cited by 157
Abortive apoptosis in Alzheimer's disease
Raina, A. K., Hochman, A., Zhu, X., Rottkamp, C. A., Nunomura, A., Siedlak, S. L., Boux, H. A., Castellani, R. J., Perry, G. L., & Smith, M. A. (2001) · Acta Neuropathologica · doi:10.1007/s004010100378 · Cited by 155
Shoulson, I. (1998) · PubMed · Cited by 154
Postmenopausal estrogen use and Parkinson's disease with and without dementia
Marder, K. S., Tang, M. X., Alfaro, B., Mejía, H., Cote, L. J., Jacobs, D. M., Stern, Y., Sano, M. C., & Mayeux, R. P. (1998) · Neurology · doi:10.1212/wnl.50.4.1141 · Cited by 153
Nelson, L. M., Matkin, C. C., Longstreth, W. T., Jr., & McGuire, V. M. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010184 · Cited by 152
Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
Vingerhoets, F. J. G., Snow, B. J., Tetrud, J. W., Langston, J. W., Schulzer, M., & Calne, D. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360513 · Cited by 151
Recent advances in amyotrophic lateral sclerosis
Al‐Chalabi, A., & Leigh, P. N. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00006 · Cited by 150
Trial of d-alpha-tocopherol in Huntington's disease
Peyser, C. E., Folstein, M. F., Chase, G. A., STARKSTEIN, S. E., Brandt, J., Cockrell, J. R., Bylsma, F., Coyle, J. T., McHugh, P. R., & Folstein, S. E. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1771 · Cited by 148
Atamna, H., Paler-Martínez, A., & Ames, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6741 · Cited by 144
FROST, M. T., Halliwell, B. B., & Moore, K. P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450453 · Cited by 144
Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson??s Disease
Ross, G. W., & Petrovitch, H. (2001) · Drugs & Aging · doi:10.2165/00002512-200118110-00001 · Cited by 143
Neuroprotective Role of Dopamine Against Hippocampal Cell Death
Bozzi, Y., Vallone, D., & Borrelli, E. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08643.2000 · Cited by 143
Risk factors of Parkinson's disease in Indian patients
Behari, M., Srivastava, A. K., Das, R. R., & Pandey, R. M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00578-0 · Cited by 142
Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease
Foley, P., & Riederer, P. F. (2000) · Journal of Neurology · doi:10.1007/pl00007766 · Cited by 138
Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease.
Brusco, L. I., Márquez, M., & Cardinali, D. P. (2000) · PubMed · Cited by 135
Andreassen, O. A., Dedeoglu, A., Klivènyi, P., Beal, M. F., & Bush, A. I. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00029 · Cited by 135
Accelerated Accumulation of Amyloid β Proteins on Oxidatively Damaged Lipid Membranes
Koppaka, V., & Axelsen, P. H. (2000) · Biochemistry · doi:10.1021/bi000619d · Cited by 131
Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study
Carlson, M. C., Zandi, P. P., Plassman, B. L., Tschanz, J. T., Welsh-Bohmer, K. A., Steffens, D. C., Bastian, L. A., Mehta, K. M., & Breitner, J. C. S. (2001) · Neurology · doi:10.1212/wnl.57.12.2210 · Cited by 129
Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients
Blanchet, P. J., Fang, J. Y., Hyland, Κ., Arnold, L. A., Mouradian, M. M., & Chase, T. N. (1999) · Neurology · doi:10.1212/wnl.53.1.91 · Cited by 129
Alzheimer disease: protective factors
Nourhashémi, F., Guyonnet, S., Andrieu, S., Ghisolfi, A., Ousset, P., Grandjean, H., Grand, A., Pous, J., Vellas, B. J., & Albaréde, J. L. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.643s · Cited by 125
Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Ferrante, K. L., Bogdanov, M. B., Kaddurah-Daouk, R. F., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00188.x · Cited by 123
Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins
Moosmann, B., & Behl, C. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01658.x · Cited by 123
Self-citationA Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
Weyer, G., Babej-Dölle, R. M., Hadler, D., Hofmann, S., & Herrmann, W. M. (2008) · Neuropsychobiology · doi:10.1159/000119366 · Cited by 120
Rodrigues, C. M. P., Linehan-Stieers, C., Keene, C. D., Ma, X., Kren, B. T., Low, W. C., & Steer, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752368.x · Cited by 120
Shults, C. W., Beal, M. F., Fontaine, D., Nakano, K., & Haas, R. (1998) · Neurology · doi:10.1212/wnl.50.3.793 · Cited by 116
Lipoic acid improves survival in transgenic mouse models of Huntington's disease
Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., & Beal, M. F. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00044 · Cited by 115
Effect of lazabemide on the progression of disability in early Parkinson's disease
Kieburtz (1996) · Annals of Neurology · doi:10.1002/ana.410400116 · Cited by 113
Moussaoui, S. M., Obinu, M. C., Daniel, N., Reibaud, M., Blanchard, V., & Impérato, A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7516 · Cited by 111
Transition metal‐mediated glycoxidation accelerates cross‐linking of β‐amyloid peptide
Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01452.x · Cited by 108
A 1-year controlled trial of acetyl- l -carnitine in early-onset AD
Thal, L. J., Calvani, M., Amato, A., & Carta, A. (2000) · Neurology · doi:10.1212/wnl.55.6.805 · Cited by 108
Assessment of coenzyme q10 tolerability in huntington's disease
Feigin, A., Kieburtz, K. D., Como, P. G., Hickey, C., Abwender, D. A., Zimmerman, C., Steinberg, K., & Shoulson, I. (1996) · Movement Disorders · doi:10.1002/mds.870110317 · Cited by 108
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P., & Breitner, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 108
Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease
Simon, D. K., Mayeux, R. P., Marder, K. S., Kowall, N. W., Beal, M. F., & Johns, D. R. (2000) · Neurology · doi:10.1212/wnl.54.3.703 · Cited by 106
Extending Functional Life Span
Harman, D. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(97)00059-4 · Cited by 105
Nakamura, K., Bindokas, V. P., Marks, J. D., Wright, D. A., Frim, D. M., Miller, R. J., & Kang, U. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.271 · Cited by 105
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
Schulz, J. B., Ross Henshaw, D., Matthews, R. T., & Flint Beal, M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90033-0 · Cited by 103
Lee, M., Hyun, D., Jenner, P. G., & Halliwell, B. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00107.x · Cited by 100
Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss
Grünblatt, E., Mandel, S. A., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00227.x · Cited by 98
Fiander, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00368-2 · Cited by 97
A controlled trial of idebenone in Huntington's disease
Ranen, N. G., Peyser, C. E., Coyle, J. T., Bylsma, F. W., Sherr, M., Day, L., Folstein, M. F., Brandt, J., Ross, C. A., & Folstein, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110510 · Cited by 97
Andreassen, O. A., Dedeoglu, A., Friedlich, A., Ferrante, K. L., Hughes, D., Szabo, C., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7633 · Cited by 96
Nakao, N., & Brundin, P. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00223-0 · Cited by 96
Ben‐Shlomo, Y., Churchyard, A., Head, J. A., Hurwitz, B., Overstall, P. W., Ockelford, J., & Lees, A. J. (1998) · BMJ · doi:10.1136/bmj.316.7139.1191 · Cited by 95
Deschamps, V., Barberger‐Gateau, P., Peuchant, E., & Orgogozo, J. M. (2001) · Neuroepidemiology · doi:10.1159/000054752 · Cited by 94
Altered redox state of platelet coenzyme Q 10 in Parkinson's disease
Götz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., & Gerlach, M. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050003 · Cited by 93
Gold, L. S., Slone, T. H., & Ames, B. N. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996318 · Cited by 93
A Therapeutic Role For Melatonin Antagonism in Experimental Models of Parkinson’s Disease
Willis, G. L., & ARMSTRONG, S. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00023-2 · Cited by 91
Can estrogen keep you smart? Evidence from clinical studies.
Sherwin, B. B. (1999) · PubMed · Cited by 89
Filip, V., & Kolibás, E. (1999) · PubMed · Cited by 88
Galeazzi, L., Ronchi, P., Franceschi, C., & Giunta, S. (1999) · Amyloid · doi:10.3109/13506129908993282 · Cited by 88
Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993
Tüchsen, F., & Jensen, A. A. (2000) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.554 · Cited by 87
Yeh, M. W., Kaul, M., Zheng, J., Nottet, H. S. L. M., Thylin, M. R., Gendelman, H. E., & Lipton, S. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4265 · Cited by 86
Malfroy, B., Doctrow, S. R., Orr, P. L., Tocco, G., Fedoseyeva, E. V., & Bénichou, G. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1091 · Cited by 86
Gutzmann, H., Kühl, K.-P., Hadler, D., & Rapp, M. A. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-19833 · Cited by 85
The Activation of Dopamine D4 Receptors Inhibits Oxidative Stress-Induced Nerve Cell Death
Ishige, K., Chen, Q., Sagara, Y., & Schubert, D. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06069.2001 · Cited by 85
Ferrante, R. J., Hantraye, P., Brouillet, E., & Beal, M. F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01166-x · Cited by 84
Fontaine, M. A. L., Geddes, J. W., Banks, A., & Butterfield, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01948-x · Cited by 84
Transgenic animal models of familial amyotrophic lateral sclerosis
Gurney, M. E. (1997) · Journal of Neurology · doi:10.1007/bf03160575 · Cited by 82
Dewachter, I., Dorpe, J. V., Spittaels, K., Tesseur, I. C., den Haute, C. V., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00149-2 · Cited by 82
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats
Shear, D. A., Haik, K. L., & Dunbar, G. L. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00007 · Cited by 81
Nagano, S., Ogawa, Y., Yanagihara, T., & Sakoda, S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00227-x · Cited by 81
Prasad, K. N., Hovland, A. R., Cole, W. C., Prasad, K. C., Nahreini, P., Edwards‐Prasad, J., & Andreatta, C. P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00002 · Cited by 79
Imam, S. Z., Crow, J. P., Newport, G. D., Islam, F., Slikker, W., & Ali, S. F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01663-7 · Cited by 77
Hormone Replacement Therapy for Oxidative Stress in Postmenopausal Women With Hot Flushes
Hernández, M. L., Díaz, J., Serrano, E., Abellán, J., & Carbonell, L. F. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00822-x · Cited by 77
A critical appraisal of the mitochondrial coenzyme Q pool
Lenaz, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03172-6 · Cited by 75
Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
Rowe, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90413-4 · Cited by 74
Choi, H. J., Jang, Y. J., Kim, H. J., & Hwang, O. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.633 · Cited by 73
Mechanisms of Neurodegenerative Disorders: Part 1: Protein Aggregates
Wolozin, B. L., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.793 · Cited by 73
Self-citationLange, D. J., Murphy, P. L., Diamond, B. E., Appel, V., Lai, E. C., Younger, D. S., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.93 · Cited by 73
Reduction of Lower Motor Neuron Degeneration inwobblerMice byN-Acetyl-l-Cysteine
Henderson, J. T., Javaheri, M., Kopko, S., & Roder, J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07574.1996 · Cited by 73
Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity
Xie, C., Lovell, M. A., & Markesbery, W. R. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00186-5 · Cited by 72
Glinka, Y., Tipton, K. F., & Youdim, M. B. H. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00279-9 · Cited by 71
Ferger, B., Teismann, P., Earl, C. D., Kuschinsky, K., & Oertel, W. H. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900079 · Cited by 71
Diabetic Glomerulopathy in Young IDDM Patients
Rudberg, S. L., & Østerby, R. (1998) · Hormone Research in Paediatrics · doi:10.1159/000053097 · Cited by 70
Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death
Moosmann, B., Skutella, T., Beyer, K., & Behl, C. (2001) · Biological Chemistry · doi:10.1515/bc.2001.195 · Cited by 70
Self-citationα‐tocopherol levels in brain are not altered in Parkinson's disease
Dexter, D. T., Jenner, P. G., Ward, R. J., Peter, T. J., Wells, F. R., Daniel, S. E., Lees, A. J., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320420 · Cited by 69
Münch, G. W., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260940 · Cited by 69
Inherited neurodegenerative diseases: the one-hit model of neurodegeneration
Clarke, G., Lumsden, C. J., & McInnes, R. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2269 · Cited by 68
Do Nonsteroidal Antiinflammatory Drugs Reduce the Risk of Alzheimer's Disease?
Breitner, J. C. S., & Zandi, P. P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111223452110 · Cited by 67
Kotsonis, P., Fröhlich, L. G., SHUTENKO, Z., Horejsi, R., Pfleiderer, W., & Schmidt, H. H. H. W. (2000) · Biochemical Journal · doi:10.1042/bj3460767 · Cited by 66
Alpha tocopherol in CSF of subjects taking high‐dose vitamin E in the DATATOP study
Vatassery, G. T., Fahn, S., & Kuskowski, M. A. (1998) · Neurology · doi:10.1212/wnl.50.6.1900 · Cited by 63
Inhibitory Effects of Tenilsetam on the Maillard Reaction
Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 61
L-deprenyl in Alzheimer's disease: Cognitive and behavioral effects
Freedman, M., Rewilak, D., Xerri, T., Cohen, S., Gordon, A. S., Shandling, M. R., & Logan, A. G. (1998) · Neurology · doi:10.1212/wnl.50.3.660 · Cited by 60
Anti-inflammatory drugs: a hope for Alzheimer’s disease?
Hüll, M., Lieb, K., & Fiebich, B. L. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.671 · Cited by 60
MPTP toxicity in the mouse brain and vitamin E
Odunze, I. N., Klaidman, L. K., & Adams, J. D., Jr. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90665-v · Cited by 59
MPP+Produces Progressive Neuronal Degeneration Which Is Mediated by Oxidative Stress
Fallon, J., Matthews, R. T., Hyman, B. T., & Beal, M. F. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6416 · Cited by 58
Kieburtz, K. D., McDermott, M., Como, P. G., Growdon, J. H., Brady, J., Carter, J., Huber, S. J., Kanigan, B., Landow, E. R., Rudolph, A., et al. (1994) · Neurology · doi:10.1212/wnl.44.9.1756 · Cited by 57
Bhavnani, B. R., Cecutti, A., Gerulath, A. H., Woolever, A. C., & Berco, M. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001222 · Cited by 57
Clapp-Lilly, K. L., Smith, M. A., Perry, G. L., Harris, P. L. R., Zhu, X., & Duffy, L. K. (2001) · Neuroreport · doi:10.1097/00001756-200105080-00044 · Cited by 55
Virmani, A., CASO, V., Spadoni, A., Rossi, S., RUSSO, F., & Gaetani, F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03623.x · Cited by 55
Ortíz, G. G., Lopez, M. E. C., Morán-Moguel, M. C., García, J. J., Reiter, R. J., & Acuña-Castroviejo, D. (2001) · PubMed · Cited by 55
Atamna, H., Robinson, C., Ingersoll, R. T., Elliott, H., & Ames, B. N. (2001) · The FASEB Journal · doi:10.1096/fj.01-0134com · Cited by 54
Bhavnani, B. R., Cecutti, A., Gerulath, A. H., Woolever, A. C., & Berco, M. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200111000-00005 · Cited by 54
Ames, B. N., & Gold, L. S. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996309 · Cited by 53
Neuroprotective effects of pramipexole in young and aged MPTP-treated mice
Anderson, D. W., Neavin, T., Smith, J. A., & Schneider, J. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02466-0 · Cited by 52
NEWS: Beta-carotene takes a collective beating
Rowe, P. (1996) · The Lancet · doi:10.5555/uri:pii:s0140673696904134 · Cited by 52
Mortality in a population with long-term exposure to inorganic selenium via drinking water
Vinceti, M., Nacci, G., Rocchi, E., Cassinadri, T. M., Vivoli, R., Marchesi, C., & Bergomi, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00233-x · Cited by 51
Perry, T. L., Yong, V. W., Hansen, S., Jones, K. L., Bergeron, C., Foulks, J. G., & Wright, J. M. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90106-7 · Cited by 50
Serum levels of coenzyme Q10 in patients with Parkinson's disease
Jiménez‐Jiménez, F. J., Molina, J. A., de Bustos, F., García‐Redondo, A., Gómez-Escalonilla, C., Martínez‐Salio, A., Berbel, Á., Camacho, A., Zurdo, M., Barcenilla, B., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050015 · Cited by 50
No Evidence for Increased Oxidative Damage to Lipids, Proteins, or DNA in Huntington's Disease
Alam, Z. I., Halliwell, B. B., & Jenner, P. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750840.x · Cited by 50
Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants
Vyth, A., Timmer, J. G., Bossuyt, P. M., Louwerse, E. S., & de Jong, J. M. B. V. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00071-8 · Cited by 49
Metal Chelator Decreases Alzheimer β-Amyloid Plaques
Gouras, G. K., & Beal, M. F. (2001) · Neuron · doi:10.1016/s0896-6273(01)00330-0 · Cited by 48
Mechanisms of Neurodegenerative Disorders: Part 2: Control of Cell Death
Wolozin, B. L., & Behl, C. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.801 · Cited by 47
Self-citationNakamura, K., Wright, D. A., Wiatr, T., Kowlessur, D., Milstien, S., Lei, X. G., & Kang, U. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742305.x · Cited by 46
Q10 therapy in patients with idiopathic Parkinson's disease
Strijks, E., Kremer, H. P. H., & Horstink, M. W. I. M. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00008-3 · Cited by 45
Estrogen use among nursing home residents with a diagnosis of Parkinson's disease
Fernandez, H. H., & Lapane, K. L. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1119::aid-mds1009>3.0.co;2-0 · Cited by 44
Nigral dopaminergic cell loss in vitamin E deficient rats
Dexter, D. T., Nanayakkara, I., Goss-Sampson, M. A., Muller, D. P. R., Harding, A. E., MARSDEN, C. D., & Jenner, P. G. (1994) · Neuroreport · doi:10.1097/00001756-199409080-00022 · Cited by 44
El-Bachá, R. D. S., Daval, J., Koziel, V., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00524-4 · Cited by 43
Poduslo, J. F., Whelan, S. L., Curran, G. L., & Wengenack, T. M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200012)48:6<943::aid-ana18>3.0.co;2-1 · Cited by 43
The Female Sex Hormone Oestrogen as Neuroprotectant: Activities at Various Levels
Behl, C., Moosmann, B., Manthey, D., & Heck, S. (2000) · Novartis Foundation symposium · doi:10.1002/0470870818.ch16 · Cited by 42
Self-citationMORGAN, W. W., & Nelson, J. F. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03106-7 · Cited by 41
Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease
The Huntington Study Group* (1998) · Neurology · doi:10.1212/wnl.50.5.1366 · Cited by 40
Abe, K., Morita, S., Kikuchi, T., & Itoyama, Y. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970401)48:1<63::aid-jnr6>3.0.co;2-c · Cited by 39
Dhanasekaran, M., & Ebadi, M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)02994-2 · Cited by 38
Dexter, D. T., Brooks, D. J., Harding, A. E., Burn, D. J., Muller, D. P. R., Goss-Sampson, M. A., Jenner, P. G., & MARSDEN, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410350309 · Cited by 38
Novel Free Radical Spin Traps Protect against Malonate and MPTP Neurotoxicity
Matthews, R. T., Klivènyi, P., Mueller, G., Yang, L., Wermer, M., Thomas, C. E., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7045 · Cited by 37
What transgenic mice tell us about neurodegenerative disease
Gurney, M. E. (2000) · BioEssays · Cited by 37
The effects of hormone replacement therapy on lipid peroxidation and antioxidant status
Serin, O., Konukoğlu, D., Kadir, Y. H., & Gülizar, K. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00216-4 · Cited by 36
The Reaction of 2-(Methylseleno)benzanilide with Peroxynitrite
Masumoto, H., & Sies, H. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9600560 · Cited by 35
Fiander, H., & Schneider, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1262 · Cited by 34
Jaarsma, D., Guchelaar, H., Haasdijk, E. D., de Jong, J. M. B. V., & Holstege, J. C. (1998) · Annals of Neurology · doi:10.1002/ana.410440229 · Cited by 34
Hirai, K., Hayako, H., Kato, K., & Miyamoto, M. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005296 · Cited by 32
Does Levodopa Accelerate Parkinson??s Disease?
Simuni, T., & Stern, M. B. (1999) · Drugs & Aging · doi:10.2165/00002512-199914060-00001 · Cited by 31
The Protective Effects of PBN Against MPTP Toxicity Are Independent of Hydroxyl Radical Trapping
Ferger, B., Teismann, P., Earl, C. D., Kuschinsky, K., & Oertel, W. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00229-4 · Cited by 28
Misconceptions on Pollution and the Causes of Cancer
Ames, B. N., & Gold, L. S. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199011971 · Cited by 28
Alafuzoff, I. I., Helisalmi, S., Heinonen, E. H., Reinikainen, K. J., Hallikainen, M., Soininen, H. S., & Koivisto, K. J. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050702 · Cited by 27
Taurine Increases Rat Survival and Reduces Striatal Damage Caused by 3-Nitropropionic Acid
Rivas-Arancibia, S., Rodríguez, A. I., Zigova, T., Willing, A. E., Brown, W. D., Cahill, D. W., & Sanberg, P. R. (2001) · International Journal of Neuroscience · doi:10.3109/00207450108986505 · Cited by 26
Blanchet, P. J., Konitsiotis, S., Hyland, Κ., Arnold, L. A., Pettigrew, K. D., & Chase, T. N. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6906 · Cited by 25
Mihatsch, W., Russ, H., Gerlach, M., Riederer, P., & Przuntek, H. (1991) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251138 · Cited by 24
BINIENDA, Z. K., Johnson, J. R., TYLER‐HASHEMI, A. A., ROUNTREE, R. L., Sapienza, P. P., Ali, S. F., & Kim, C. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07992.x · Cited by 23
Pyruvate protects against 3-nitropropionic acid neurotoxicity in corticostriatal slice cultures
Gramsbergen, J. B., Sandberg, M., Kornblit, B. T., & Zimmer, J. (2000) · Neuroreport · doi:10.1097/00001756-200008210-00027 · Cited by 22
Karlsson, J., Emgård, M., Rosenblad, C., & Brundin, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00702-1 · Cited by 19
Dietary Phenols: Antioxidants for the Brain?
Moosmann, B., & Behl, C. (2000) · Nutritional Neuroscience · doi:10.1080/1028415x.2000.11747298 · Cited by 17
Self-citationBiochemistry of Neurodegeneration
Perry, G. L., Ávila, J., Espey, M. G., Wink, D. A., Atwood, C., & Smith, M. A. (2001) · Science · doi:10.1126/science.291.5504.595c · Cited by 14
An Investigation into the Neuroprotective Properties of Ibuprofen
Lambat, Z., Conrad, N., Anoopkumar‐Dukie, S., Walker, R. B., & Daya, S. (2000) · Metabolic Brain Disease · doi:10.1023/a:1011115006856 · Cited by 13
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
Microwave-Assisted Extraction of Flavonoids: A Review
Routray, W., & Orsat, V. (2012) · Food and Bioprocess Technology · doi:10.1007/s11947-011-0573-z · Cited by 676
Metadata
- Authors
- Moosmann, B., & Behl, C.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2002-10
- Volume
- 11
- Issue
- 10
- Pages
- 1407-1435
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2032008117
- Cited by
- 252
- References
- 365
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.